Day Trader’s Weekend Aftermarket Lounge 21-23 Feb 2020, page-205

Peter Molloy is a hardworking chemist , former head of Pfizer Southern Hemisphere back in time .,
He has seen drugs and treatments be rejected or dropped before commercialisation by big Pharmaceutical companies .
He was instrumental in at least 40 major drugs being commercialised .
He branched out on his own project - and was the creator , of the now global leading throat gargle for strep throat , throat inventions -he developed it from betadine .
It is simple , truly effective , not false efficacy or merely a symptom relieving treatment.
He also hastened the halt of sales of detrimental , and unwise throat cough medicines that used to be sold over the counter until into the 2000s.

With this viral nasal spray - he states that they are not seeking to make money .
”Pandemics are not the time for making money” he believes .
Of course the product , as with Gileads drug treatment which they have provided for free to the chinese people also for testing and treatment - **very valuable data will come out of trial use . **

Peter mainly is working on Bisantrene however - a chemotherapy drug to be resurrected and finally commercialised . RAC .

Several world leading oncologists , each with their own global leading past breakthroughs, have come on board the clinical team in the US . Another preeminent fellow this last week .
Peter Molloy is CEO of Race Oncology .
He is effective , respected , and has global connections to bring treatments into consideration for trial ,
and through processes ultimately to market .

Sorry - saw your post .
And had to say Peter is also CEO of RAC.